We report the synthesis and structural diversity of Zn(II) metal-organic framework (MOF)
with in situ formation of tetrazole ligand
3-ptz
[
3-ptz
= 5-(3-pyridyl)tetrazolate] as a function pH. By varying
the initial reaction pH, we obtain high-quality crystals of the noncentrosymmetric
three-dimensional MOF
Zn(3-ptz)
2
, mixed phases
involving the zinc-aqua complex [Zn(H
2
O)
4
(3-ptz)
2
]·4H
2
O, and two-dimensional MOF crystals Zn(OH)(3-ptz)
with a tunable microrod morphology, keeping reaction time, temperature,
and metal–ligand molar ratio constant. Structures are characterized
by X-ray diffraction, scanning electron microscopy, Fourier transform
infrared spectroscopy, and UV–vis spectroscopy. We discuss
the observed structural diversity in terms of the relative abundance
of hydroxo-zinc species in solution for different values of pH.
A series of new triazolium-based supported ionic liquids (SILPs), decorated with Cu NPs, were successfully prepared and applied to the N-arylation of aryl halides with anilines.
The spectroscopic, electrochemical and photophysical properties of the first Re organometallic organoimido-polyoxometalate complex [n-BuN][MoONCH-CH-NCH-Re-phen(CO)] compared with all fragments are reported. The UV-Vis spectra are analysed using experimental and theoretical tools. In contrast to the reported studies in the literature, our results show that a new more intense band is present in the spectra of the hybrid ligand obscuring the intra-polyanion charge transfer. The electrochemical results show that the strong acceptor character of the polyoxometalate fragment is quenched by the condensation of the phenyl-triazole molecule.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.